Prof. Chamindie Punyadeera is an inventor and an ambassador to women in STEMM. She has had a hybrid research career working in industry as well as in academia. She has worked at Philips Electronics in the Netherlands and has been instrumental in developing Philips Mini-care I-20 for cardiac disease detection. She has also contributed to the development of an integrated platform to detect nucleic acids (Idylla TM) commercialised by Biocartis NV (Belgium). She is a globally acknowledged pioneer in salivary diagnostics. She is a consultant to Oasis Diagnostics®, USA and FLUIDS iQ™, Montreal, Canada. She leads a world-class saliva research laboratory in Australia, > 15 researchers focusing on developing novel salivary technologies to detect heart disease and the application of liquid biopsy to accelerate precision treatment in cancers. She is the convenor of the inaugural saliva conference in Australasia in 2016, which is now a national conference. Prof. Punyadeera has 127 publications, 8 invited book chapters, cited >6000 times with a h-index of 42. She has also produced 18 PCT applications and in the process of licensing salivary oral cancer test. Her team is also developing prognostic assays to identify patients likely to develop recurrences using circulating tumour cells. She has partnered with Viome (USA) in translating saliva based test to predict oral and throat cancer- which received FDA approval in 2021. She has delivered key note and invited lecturers both nationally and internationally. She is a grant reviewer for both national and international funding agencies and currently serves on the Editorial Board of the Journal of Oral Oncology, associate editor BMC Genomics and a guest editor to BMC Medical Genomics, Diagnostics and Biomolecules.